TE HEALTHCARE Posts September 2026 Monthly Return: No Share Capital Changes, Public Float Maintained

Bulletin Express
Oct 02

Top Eminent Healthcare Group Limited (TE HEALTHCARE) filed its Monthly Return for Equity Issuers for the period ended 30 September 2026, confirming a stable capital structure and full compliance with Hong Kong’s public-float requirements. The disclosure was submitted to Hong Kong Exchanges and Clearing Limited on 2 October 2026.

The company’s authorised share capital remained unchanged at 4.00 billion ordinary shares with a par value of HKD 0.01 each, representing authorised capital of HKD 40.00 million.

Issued share capital closed the month at 2.03 billion ordinary shares, identical to the preceding month’s level. No treasury shares were held or cancelled, and no new shares were issued or repurchased during September. As a result, 1.97 billion authorised shares—equivalent to 49.17 % of total authorised capital—remain unissued.

TE HEALTHCARE affirmed that it satisfied the Main Board’s minimum public-float threshold of 25 % as of 30 September 2026.

The filing also states that the company had no outstanding share option schemes, warrants, convertible securities, or other equity-issuance arrangements during the reporting month.

Overall, the September return signals a month of equity stability for TE HEALTHCARE, with no movements in authorised or issued share capital and continued adherence to listing rules on public float.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10